NYSEAMERICAN:AMPE - Ampio Pharmaceuticals Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$2.05 -0.11 (-5.09 %)
(As of 05/27/2018 10:15 AM ET)
Previous Close$2.05
Today's Range$1.93 - $2.20
52-Week Range$0.38 - $4.95
Volume905,723 shs
Average Volume1.04 million shs
Market Capitalization$197.70 million
P/E RatioN/A
Dividend YieldN/A
Beta0.51

About Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)

Ampio Pharmaceuticals logoAmpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, an oral agent for the treatment of diabetic macular edema. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.

Receive AMPE News and Ratings via Email

Sign-up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryPharmaceuticals
SectorMedical
SymbolNYSEAMERICAN:AMPE
CUSIP03209T10
Phone+1-720-4376500

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-965.03%
Return on Assets-151.95%

Miscellaneous

EmployeesN/A
Outstanding Shares86,320,000

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Frequently Asked Questions

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "AMPE."

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) released its earnings results on Tuesday, February, 24th. The specialty pharmaceutical company reported ($0.19) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.20) by $0.01. The specialty pharmaceutical company had revenue of $0.02 million for the quarter. View Ampio Pharmaceuticals' Earnings History.

Are investors shorting Ampio Pharmaceuticals?

Ampio Pharmaceuticals saw a increase in short interest in May. As of May 15th, there was short interest totalling 11,209,042 shares, an increase of 1.9% from the April 30th total of 10,998,734 shares. Based on an average trading volume of 466,665 shares, the short-interest ratio is currently 24.0 days. Currently, 14.7% of the company's shares are short sold.

Who are some of Ampio Pharmaceuticals' key competitors?

Who are Ampio Pharmaceuticals' key executives?

Ampio Pharmaceuticals' management team includes the folowing people:
  • Mr. Michael Macaluso, Founder, Chairman & CEO (Age 66)
  • Mr. Thomas E. Chilcott III, CFO & Sec. (Age 50)
  • Ms. Holli Cherevka, Chief Operating Officer (Age 35)
  • Dr. David Bar-Or M.D., Chief Scientific Officer & Director (Age 69)
  • Mr. Philip H. Coelho, Director (Age 74)

Has Ampio Pharmaceuticals been receiving favorable news coverage?

Media headlines about AMPE stock have trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Ampio Pharmaceuticals earned a news impact score of 0.07 on Accern's scale. They also assigned news coverage about the specialty pharmaceutical company an impact score of 47.24 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Who are Ampio Pharmaceuticals' major shareholders?

Ampio Pharmaceuticals' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Millennium Management LLC (0.91%), Tibra Equities Europe Ltd (0.20%), Cypress Capital Management LLC WY (0.20%), Prosight Management LP (0.13%), Noven Financial Group Inc. (0.12%) and Brighton Jones LLC (0.10%). View Institutional Ownership Trends for Ampio Pharmaceuticals.

Which institutional investors are selling Ampio Pharmaceuticals stock?

AMPE stock was sold by a variety of institutional investors in the last quarter, including Noven Financial Group Inc.. View Insider Buying and Selling for Ampio Pharmaceuticals.

Which institutional investors are buying Ampio Pharmaceuticals stock?

AMPE stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Tibra Equities Europe Ltd, Prosight Management LP, Element Capital Management LLC, A.R.T. Advisors LLC, Cypress Capital Management LLC WY and Brighton Jones LLC. View Insider Buying and Selling for Ampio Pharmaceuticals.

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $2.05.

How big of a company is Ampio Pharmaceuticals?

Ampio Pharmaceuticals has a market capitalization of $197.70 million.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States. The specialty pharmaceutical company can be reached via phone at +1-720-4376500.


MarketBeat Community Rating for Ampio Pharmaceuticals (AMPE)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  78 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  145
MarketBeat's community ratings are surveys of what our community members think about Ampio Pharmaceuticals and other stocks. Vote "Outperform" if you believe AMPE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMPE will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Consensus Price Target History

Price Target History for Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
6/30/2016Janney Montgomery ScottReiterated RatingPositiveView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Earnings History and Estimates Chart

Earnings by Quarter for Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)

Ampio Pharmaceuticals (NYSEAMERICAN AMPE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2017Q2 2017($0.04)ViewN/AView Earnings Details
5/12/2017Q1 2017($0.05)ViewN/AView Earnings Details
3/16/2017Q4 2016($0.05)ViewN/AView Earnings Details
11/8/2016Q3 2016($0.06)ViewN/AView Earnings Details
8/2/2016Q2 2016($0.10)ViewN/AView Earnings Details
5/6/2016Q1 2016($0.13)ViewN/AView Earnings Details
2/26/2016Q4 2015($0.19)$0.47 millionViewN/AView Earnings Details
11/6/2015Q3 2015($0.14)$0.49 millionViewN/AView Earnings Details
8/7/2015Q2 2015($0.14)$0.18 millionViewN/AView Earnings Details
5/8/2015Q1 2015($0.14)$0.02 millionViewN/AView Earnings Details
2/24/2015($0.20)($0.19)$0.02 millionViewN/AView Earnings Details
11/12/2014($0.17)($0.18)$0.02 million$0.02 millionViewN/AView Earnings Details
8/12/2014($0.24)($0.17)$0.01 million$0.02 millionViewN/AView Earnings Details
5/7/2014Q1 2014($0.23)$0.01 millionViewN/AView Earnings Details
2/14/2014Q4 2013($0.18)$0.01 millionViewN/AView Earnings Details
11/8/2013Q3 2013($0.16)$0.01 millionViewN/AView Earnings Details
8/9/2013Q2 2013($0.17)$0.01 millionViewN/AView Earnings Details
5/3/2013Q1 2013($0.11)$0.01 millionViewN/AView Earnings Details
3/5/2013Q4 2012($0.10)ViewN/AView Earnings Details
11/2/2012Q3 2012($0.07)ViewN/AView Earnings Details
8/3/2012Q2 2012($0.08)ViewN/AView Earnings Details
5/4/2012Q1 2012($0.09)ViewN/AView Earnings Details
2/9/2012Q4 2011($0.14)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Ampio Pharmaceuticals (NYSEAMERICAN AMPE) Insider Trading and Institutional Ownership History

Insider Trading History for Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)
Institutional Ownership by Quarter for Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)

Ampio Pharmaceuticals (NYSEAMERICAN AMPE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/27/2017Philip H CoelhoDirectorBuy10,000$0.63$6,300.00104,727View SEC Filing  
9/22/2017Philip H CoelhoDirectorBuy3,000$0.60$1,800.0091,727View SEC Filing  
9/20/2017Philip H CoelhoDirectorBuy1,000$0.59$590.0091,727View SEC Filing  
9/19/2017Philip H CoelhoDirectorBuy15,000$0.57$8,550.0090,727View SEC Filing  
9/5/2017Philip H CoelhoDirectorBuy30,000$0.56$16,800.0075,727View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Ampio Pharmaceuticals (NYSEAMERICAN AMPE) News Headlines

Source:
DateHeadline
Ampio Pharmaceuticals, Inc. (AMPE) Sees Significant Increase in Short InterestAmpio Pharmaceuticals, Inc. (AMPE) Sees Significant Increase in Short Interest
www.americanbankingnews.com - May 24 at 5:25 PM
Ampio Updates Scientific presentations and publications on Ampion™Ampio Updates Scientific presentations and publications on Ampion™
finance.yahoo.com - May 22 at 9:24 AM
The Forecast For Ampio Pharmaceuticals: Dilution With A Chance Of InsolvencyThe Forecast For Ampio Pharmaceuticals: Dilution With A Chance Of Insolvency
seekingalpha.com - May 16 at 9:53 AM
Warrant You Glad Youre Not Long Ampio?Warrant You Glad You're Not Long Ampio?
seekingalpha.com - May 15 at 10:13 AM
Ampio Provides Corporate UpdateAmpio Provides Corporate Update
www.prnewswire.com - May 14 at 8:49 AM
Ampio Pharmaceuticals, Inc. (AMPE) Short Interest UpdateAmpio Pharmaceuticals, Inc. (AMPE) Short Interest Update
www.americanbankingnews.com - May 9 at 5:49 PM
The Pivotal Trial Results on Ampion™ (AP-003-C) Was Accepted for Publication in a Peer-Reviewed Medical JournalThe Pivotal Trial Results on Ampion™ (AP-003-C) Was Accepted for Publication in a Peer-Reviewed Medical Journal
finance.yahoo.com - May 2 at 9:34 AM
Who Really Owns Ampio Pharmaceuticals Inc (NYSEMKT:AMPE)?Who Really Owns Ampio Pharmaceuticals Inc (NYSEMKT:AMPE)?
finance.yahoo.com - May 1 at 4:16 PM
Short Interest in Ampio Pharmaceuticals, Inc. (AMPE) Expands By 11.8%Short Interest in Ampio Pharmaceuticals, Inc. (AMPE) Expands By 11.8%
www.americanbankingnews.com - April 24 at 6:38 PM
AMPIO PHARMACEUTICALS, INC.AMPIO PHARMACEUTICALS, INC.
www.streetinsider.com - April 17 at 9:58 AM
The Battle For Ampio Pharmaceuticals Reaches Inflection Point As Shorts Run Out Of GasThe Battle For Ampio Pharmaceuticals Reaches Inflection Point As Shorts Run Out Of Gas
seekingalpha.com - April 13 at 4:20 PM
How Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) Can Impact Your Portfolio VolatilityHow Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) Can Impact Your Portfolio Volatility
finance.yahoo.com - April 13 at 4:20 PM
Ampio Updates Regulatory, Clinical and NYSE ActivitiesAmpio Updates Regulatory, Clinical and NYSE Activities
finance.yahoo.com - April 13 at 10:07 AM
Ampio Pharmaceuticals: Cash Critically Low, Pattern Of Exaggerated Claims ContinuesAmpio Pharmaceuticals: Cash Critically Low, Pattern Of Exaggerated Claims Continues
seekingalpha.com - April 12 at 10:35 AM
Ampio Pharmaceuticals, Inc. (AMPE) Short Interest Up 2.5% in MarchAmpio Pharmaceuticals, Inc. (AMPE) Short Interest Up 2.5% in March
www.americanbankingnews.com - April 10 at 6:56 PM
Ampio Pharma (AMPE) Announces Update on Regulatory and Clinical ActivitiesAmpio Pharma (AMPE) Announces Update on Regulatory and Clinical Activities
www.streetinsider.com - April 5 at 4:18 PM
Ampio Updates Regulatory and Clinical ActivitiesAmpio Updates Regulatory and Clinical Activities
finance.yahoo.com - April 3 at 9:59 AM
Ampio Pharmaceuticals Inc (AMPE) Sees Large Increase in Short InterestAmpio Pharmaceuticals Inc (AMPE) Sees Large Increase in Short Interest
www.americanbankingnews.com - March 26 at 6:54 PM
Ampio Pharmas Ampion shows potential effect in delaying total knee replacementAmpio Pharma's Ampion shows potential effect in delaying total knee replacement
seekingalpha.com - March 26 at 4:11 PM
Evidence for Delay of Total Knee Replacement (TKR) for Patients with Severe Osteoarthritis of the Knee Receiving Three Intra-articular (IA) Ampion™ InjectionsEvidence for Delay of Total Knee Replacement (TKR) for Patients with Severe Osteoarthritis of the Knee Receiving Three Intra-articular (IA) Ampion™ Injections
finance.yahoo.com - March 26 at 10:06 AM
Ampio Pharmaceuticals Provides Corporate Update Following Conference CallAmpio Pharmaceuticals Provides Corporate Update Following Conference Call
finance.yahoo.com - March 16 at 9:59 AM
Ampio Pharmas Statements And Actions Are Inconsistent With Its Claimed Partnership Negotiations - Seeking AlphaAmpio Pharma's Statements And Actions Are Inconsistent With Its Claimed Partnership Negotiations - Seeking Alpha
seekingalpha.com - March 12 at 5:20 PM
Ampio Pharmaceuticals Inc (AMPE) Short Interest UpdateAmpio Pharmaceuticals Inc (AMPE) Short Interest Update
www.americanbankingnews.com - March 9 at 6:23 PM
Ampio Hosting Conference Call, Wednesday, March 7, 5:00 pm ESTAmpio Hosting Conference Call, Wednesday, March 7, 5:00 pm EST
finance.yahoo.com - March 7 at 9:46 AM
Pre-Market Technical Scan on Biotech Equities -- Amicus Therapeutics, Ampio Pharmaceuticals, AmpliPhi Biosciences, and ARMO BioSciencesPre-Market Technical Scan on Biotech Equities -- Amicus Therapeutics, Ampio Pharmaceuticals, AmpliPhi Biosciences, and ARMO BioSciences
www.bizjournals.com - March 6 at 9:31 AM
Short Interest in Ampio Pharmaceuticals Inc (AMPE) Grows By 1.5%Short Interest in Ampio Pharmaceuticals Inc (AMPE) Grows By 1.5%
www.americanbankingnews.com - February 27 at 6:00 PM
Here's Why Ampio Pharmaceuticals Dropped as Much as 18.8% TodayHere's Why Ampio Pharmaceuticals Dropped as Much as 18.8% Today
finance.yahoo.com - February 16 at 4:27 PM
Is Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) Still A Cheap Healthcare Stock?Is Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) Still A Cheap Healthcare Stock?
finance.yahoo.com - February 13 at 4:34 PM
Biotech Stocks Research Reports Released on Ampio Pharma, AmpliPhi Biosciences, Actinium Pharma, and BioPharmXBiotech Stocks' Research Reports Released on Ampio Pharma, AmpliPhi Biosciences, Actinium Pharma, and BioPharmX
www.bizjournals.com - January 25 at 9:01 AM
Ampio Pharmaceuticals Inc (AMPE) Sees Large Growth in Short InterestAmpio Pharmaceuticals Inc (AMPE) Sees Large Growth in Short Interest
www.americanbankingnews.com - January 24 at 6:10 PM
Is Ampio Pharmaceuticals Inc’s (NYSEMKT:AMPE) CEO Salary Justified?Is Ampio Pharmaceuticals Inc’s (NYSEMKT:AMPE) CEO Salary Justified?
finance.yahoo.com - January 22 at 5:42 PM
Ampio Update of J.P. Morgan Meeting Events and Disease Modification DiscussionsAmpio Update of J.P. Morgan Meeting Events and Disease Modification Discussions
finance.yahoo.com - January 16 at 8:57 AM
What Does Ampio Pharmaceuticals Inc’s (NYSEMKT:AMPE) Ownership Structure Look Like?What Does Ampio Pharmaceuticals Inc’s (NYSEMKT:AMPE) Ownership Structure Look Like?
finance.yahoo.com - January 15 at 3:28 PM
Short Interest in Ampio Pharmaceuticals Inc (AMPE) Increases By 9.6%Short Interest in Ampio Pharmaceuticals Inc (AMPE) Increases By 9.6%
www.americanbankingnews.com - January 10 at 5:38 PM
Ampio Presentation at JP Morgan Healthcare Conference made available to all Shareholders - PR Newswire (press release)Ampio Presentation at JP Morgan Healthcare Conference made available to all Shareholders - PR Newswire (press release)
www.prnewswire.com - January 8 at 9:32 AM
Ampio Presentation at J.P. Morgan Healthcare Conference made available to all ShareholdersAmpio Presentation at J.P. Morgan Healthcare Conference made available to all Shareholders
finance.yahoo.com - January 8 at 9:32 AM
Did Ampio Pharmaceuticals Inc’s (NYSEMKT:AMPE) Recent Earnings Growth Beat The Trend?Did Ampio Pharmaceuticals Inc’s (NYSEMKT:AMPE) Recent Earnings Growth Beat The Trend?
finance.yahoo.com - January 4 at 3:28 PM
Heres Why Ampio Pharmaceuticals Sank as Much as 13.5% TodayHere's Why Ampio Pharmaceuticals Sank as Much as 13.5% Today
www.fool.com - January 3 at 5:59 PM
Here's Why Ampio Pharmaceuticals Sank as Much as 13.5% TodayHere's Why Ampio Pharmaceuticals Sank as Much as 13.5% Today
finance.yahoo.com - January 3 at 5:59 PM
Why Ampio Pharmaceuticals Rose as Much as 15% TodayWhy Ampio Pharmaceuticals Rose as Much as 15% Today
finance.yahoo.com - December 28 at 1:46 PM
Ampio Pharmaceuticals Inc (AMPE) Rallies as Knee Osteoarthritis Drug Findings CheerAmpio Pharmaceuticals Inc (AMPE) Rallies as Knee Osteoarthritis Drug Findings Cheer
finance.yahoo.com - December 14 at 3:29 PM
Colorado biotechs knee osteoarthritis drug gets good results, stock soarsColorado biotech's knee osteoarthritis drug gets good results, stock soars
www.bizjournals.com - December 14 at 10:59 AM
Ampio Pharma (AMPE) Phase 3 Trial of Ampion in Severe Osteoarthritis-of-the Knee Meets Primary, Secondary ... - StreetInsider.comAmpio Pharma (AMPE) Phase 3 Trial of Ampion in Severe Osteoarthritis-of-the Knee Meets Primary, Secondary ... - StreetInsider.com
www.streetinsider.com - December 14 at 8:55 AM
Ampio Pharmaceuticals Reports Positive Results for both Primary and Secondary Endpoints of Pivotal Phase 3 Trial of Ampion™ in Severe Osteoarthritis-of-the Knee (OAK)Ampio Pharmaceuticals Reports Positive Results for both Primary and Secondary Endpoints of Pivotal Phase 3 Trial of Ampion™ in Severe Osteoarthritis-of-the Knee (OAK)
finance.yahoo.com - December 14 at 8:55 AM
Today’s Research Reports on Stocks to Watch: Ampio Pharmaceuticals and VersartisToday’s Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Versartis
finance.yahoo.com - December 4 at 8:46 AM
Ampio Pharmaceuticals Announces Engagement of LaVoieHealthScience for Integrated Public and Investor Relations - PR Newswire (press release)Ampio Pharmaceuticals Announces Engagement of LaVoieHealthScience for Integrated Public and Investor Relations - PR Newswire (press release)
www.prnewswire.com - November 30 at 9:43 AM
Ampio Pharmaceuticals Announces Engagement of LaVoieHealthScience for Integrated Public and Investor RelationsAmpio Pharmaceuticals Announces Engagement of LaVoieHealthScience for Integrated Public and Investor Relations
finance.yahoo.com - November 30 at 8:59 AM
Short Interest in Ampio Pharmaceuticals Inc (AMPE) Rises By 25.3%Short Interest in Ampio Pharmaceuticals Inc (AMPE) Rises By 25.3%
www.americanbankingnews.com - November 27 at 7:48 PM
Health Care Sector Update for 11/22/2017: AMPE,KALA,CHFS - NasdaqHealth Care Sector Update for 11/22/2017: AMPE,KALA,CHFS - Nasdaq
www.nasdaq.com - November 22 at 4:27 PM
Ampio Pharma (AMPE) Announces Publication of Article on Ampion in Orthopedics Peer-Reviewed Journal - StreetInsider.comAmpio Pharma (AMPE) Announces Publication of Article on Ampion in Orthopedics Peer-Reviewed Journal - StreetInsider.com
www.streetinsider.com - November 22 at 4:27 PM

SEC Filings

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Ampio Pharmaceuticals (NYSEAMERICAN AMPE) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.